Search global stocks & ETFs...Ctrl K
Learn Mode
GEHC
Stock Profile
10-26
Recommended Metric
Score Card
Explore Scores Tab
3.50
Good
Valuation Score
Key Score
2.00
Bad
Management
1.00
Very Bad
Growth
3.00
Average
Profitability
5.00
Very Good
Fin. Health
2.00
Bad
Dividends
3.00
Average
Analyst
4.00
Good
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending Jun 28, 2027
Current
$67.51
Baseline
High
$102.90
▲
52.42%
Avg
$82.37
▲
22.02%
Low
$65.65
▼
-2.76%
Analyst Ratings based on 28 Analysts
Strong Buy
829%
Buy
1139%
Hold
932%
Sell
000%
Strong Sell
000%
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.Read More